Neoadjuvant Tislelizumab Combined with Chemoradiotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Single-Arm Phase II Study and Exploration of Immunologic Features

被引：0
|
作者：
Jin, P. [1 ]
Gao, Y. [1 ]
Fu, Z. [1 ]
Yang, W. [1 ]
Meng, X. [2 ]
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Peoples R China
[2] Shandong Canc Hosp & Inst, Jinan, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3003
引用
收藏
页码：E454 / E454
页数：1
相关论文
共 50 条
  • [31] Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: A prospective, single-arm, phase II study (TD-NICE)
    Yan, Xiaolong
    Duan, Hongtao
    Ni, Yunfeng
    Zhou, Yongan
    Wang, Xiaoping
    Qi, Haini
    Gong, Li
    Liu, Honggang
    Tian, Feng
    Lu, Qiang
    Sun, Jianyong
    Yang, Ende
    Zhong, Daixing
    Wang, Tao
    Huang, Lijun
    Wang, Jian
    Wang, Chaoyang
    Wang, Yuanyong
    Wan, Zhiyi
    Lei, Jie
    Zhao, Jinbo
    Jiang, Tao
    INTERNATIONAL JOURNAL OF SURGERY, 2022, 103
  • [32] Toripalimab combined with definitive chemoradiotherapy for locally advanced cervical squamous cell carcinoma patients (TRACE): A single-arm, phase I/II trial
    Ou, Dan
    Cai, Rong
    Qi, Wei-Xiang
    Cui, Can
    Cao, Lu
    Wang, Shu-Bei
    Li, Huan
    Ma, Tao
    Miao, Ying
    Xu, Cheng
    Cai, Gang
    Cao, Wei-Guo
    Gao, Yun-Sheng
    Chen, Jia-Yi
    Xu, Hao-Ping
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (12)
  • [33] Safety and efficacy of camrelizumab combined with radiotherapy as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a prospective single-arm phase II clinical trial protocol
    Maohui Chen
    Yizhou Huang
    Shuliang Zhang
    Taidui Zeng
    Guanglei Huang
    Chun Chen
    Bin Zheng
    Trials, 24 (1)
  • [34] Tislelizumab combined with chemotherapy or radiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma (TINES): A randomized, open, phase II study
    Zhang, Yong
    Che, Shaomin
    Chen, Nanzheng
    Li, Xinju
    Fu, Junke
    Yu, Chenao
    Wang, Tianren
    Liang, Runjia
    Xu, Haozhen
    Wu, Qifei
    Jia, Zhuoqi
    Zhu, Cailin
    Gong, Tuotuo
    Li, Haijun
    Zhang, Boxiang
    Hu, Yunyun
    Liu, Yaqi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] Safety and efficacy of camrelizumab combined with radiotherapy as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a prospective single-arm phase II clinical trial protocol
    Chen, Maohui
    Huang, Yizhou
    Zhang, Shuliang
    Zeng, Taidui
    Huang, Guanglei
    Chen, Chun
    Zheng, Bin
    TRIALS, 2023, 24 (01)
  • [36] Evaluation of the safety and effectiveness of neoadjuvant combined chemoimmunotherapy in the treatment of locally advanced esophageal squamous cell carcinoma: a retrospective single-arm cohort study
    Xia, Pinghui
    Li, Pan
    Wu, Simeng
    Wang, Yiqing
    Ye, Peng
    Zhang, Chong
    Hu, Jian
    Kidane, Biniam
    Lampridis, Savvas
    Velotta, Jeffrey B.
    Wakefield, Connor J.
    Zhu, Linhai
    Wang, Luming
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (18)
  • [37] A Phase II Clinical Trial of Sintilimab Combined with Lower Dose Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
    Liu, Y.
    Chen, Y.
    Yu, R.
    Zou, B.
    Zhou, X.
    Gong, Y.
    Peng, F.
    Hu, Y.
    Wang, W.
    Yuan, Y.
    Chen, L.
    Tian, D.
    Yu, M.
    Li, Y.
    Lu, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E433 - E434
  • [38] Safety and feasibility of neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced esophageal squamous cell carcinoma: a prospective single-group phase II clinical study
    Cheng, Lei
    Wang, Xinyi
    Shen, Haixia
    Wang, Jin
    Yang, Yang
    Wu, Wei
    Mehmood, Rashid
    Shen, Dijian
    Jiang, Youhua
    Ji, Yongling
    JOURNAL OF THORACIC DISEASE, 2024, 16 (10) : 7029 - 7041
  • [39] Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma (RICE): A Prospective, Single-Arm, Phase II Trial
    Lin, L.
    Li, H.
    Zhao, L.
    Cheng, Y.
    Liu, M. N.
    Fu, X.
    Liu, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E464 - E465
  • [40] Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial)
    Huang, Yingying
    Sun, Jingjing
    Li, Jun
    Zhu, Dongwang
    Dong, Minjun
    Dou, Shengjin
    Tang, Yong
    Shi, Wentao
    Sun, Qi
    Zhao, Tongchao
    Zhou, Zhihang
    Zhou, Xinyu
    Liu, Ying
    Li, Jiang
    Zhu, Guopei
    Zhang, Ding
    Chen, Yanan
    Zhu, Qi
    Ju, Wutong
    Zhong, Laiping
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (08) : 2220 - 2227
12345